NCT04191434View on ClinicalTrials.gov

Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma

PHASE3UnknownINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

October 31, 2023

Conditions
Asthma
Interventions
DRUG

Flamboyant 125/12

Flamboyant 125/12 capsule

DRUG

Budesonide/formoterol 200/6

Budesonid/formoterol 200/6 capsule

OTHER

Flamboyant 125/12 Placebo

Flamboyant 125/12 Placebo capsule

OTHER

Budesonide/formoterol 200/6 placebo

Budesonid/formoterol 200/6 Placebo capsule

Trial Locations (3)

Unknown

RECRUITING

Insight Pesquisa Clínica, Porto Alegre

RECRUITING

IMC Tatuí, Tatuí

RECRUITING

CPCLin, São Paulo

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY

NCT04191434 - Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma | Biotech Hunter | Biotech Hunter